|
US2016082037A1
|
|
Composition, preparation, and use of chitosan powder for biomedical applications
|
|
AU2014280979A1
|
|
Systems and methods for characterizing spatial distortion in 3D imaging systems
|
|
WO2015021303A1
|
|
Systems and methods for the treatment of bladder cancer
|
|
US2015050349A1
|
|
Systems and methods for particle radiation enhanced delivery of therapy
|
|
US2014200448A1
|
|
Proton scattering analysis system
|
|
WO2013138368A1
|
|
Substances and methods for the treatment of cerebral amyloid angiopathy related conditions or diseases
|
|
US8644571B1
|
|
Intensity-modulated proton therapy
|
|
WO2012161852A2
|
|
Systems, devices and methods related to calibration of a proton computed tomography scanner
|
|
AU2011236126A1
|
|
Modular Patient Support System
|
|
AU2011224101A1
|
|
Method and Device for Registration and Immobilization
|
|
AU2011218678A1
|
|
Vascular Wound Closure Device
|
|
WO2011106440A1
|
|
Method of analyzing a medical image
|
|
EP2504039A1
|
|
Chitosan-based hemostatic textile
|
|
EP2483710A1
|
|
Ion induced impact ionization detector and uses thereof
|
|
WO2011003037A1
|
|
Devices and methods for performing percutaneous surgical procedures
|
|
US2010143924A1
|
|
Negative correlation between irp-2 and transferrin receptor expression as a diagnostic of alzheimer's disease
|
|
AU2009217348A1
|
|
Systems and methods for characterizing spatial distortion in 3D imaging systems
|
|
AU2008202723A1
|
|
Iron Regulating Protein-2 (IRP-2) as a Diagnostic For Neurodegenerative Disease
|
|
CN101641748A
|
|
Device and method for immobilizing patients for breast radiation therapy
|
|
US2008264708A1
|
|
Mobile Telemedicine Vehicle
|
